Rilpivirine
- Part D specialty tier in 76% of formularies (2026Q3)
- EDURANT
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Rilpivirine: storage and handling
- Freezing
- Not addressed
- Room temperature
- at or below 30°C (86°F)
Label statement
Store EDURANT tablets at 20° to 25°C (68° to 77°F); with excursions permitted to 15° to 30°C (59° to 86°F) [see USP controlled room temperature].
- Room temperature
- at or below 30°C (86°F)
Label statement
Store at 20° to 25°C (68° to 77°F); with excursions permitted to 15° to 30°C (59° to 86°F) [see USP controlled room temperature].
- Room temperature
- at or below 25°C (77°F)
Label statement
Store EDURANT PED at room temperature between 68°F to 77°F (20°C to 25°C).
- Room temperature
- at or below 25°C (77°F)
Label statement
Store EDURANT or EDURANT PED at room temperature between 68°F to 77°F (20°C to 25°C).
- Back into the refrigerator
- Not addressed
- Light
- Protect from light
Label statement
Store EDURANT tablets in the original bottle in order to protect from light.
- Shaking
- Not addressed
All storage statements on the label (8)
- Store EDURANT tablets in the original bottle in order to protect from light.
- Store EDURANT tablets at 20° to 25°C (68° to 77°F); with excursions permitted to 15° to 30°C (59° to 86°F) [see USP controlled room temperature].
- Store EDURANT PED tablets for oral suspension in the original package in order to protect from light and moisture.
- Store at 20° to 25°C (68° to 77°F); with excursions permitted to 15° to 30°C (59° to 86°F) [see USP controlled room temperature].
- Store EDURANT PED at room temperature between 68°F to 77°F (20°C to 25°C).
- Keep EDURANT PED tablets in the original package to protect from light and moisture.
- Store EDURANT or EDURANT PED at room temperature between 68°F to 77°F (20°C to 25°C).
- Keep EDURANT tablets in the original bottle to protect from light.
FDA label version 28, effective August 28, 2025. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.